Balance Sheet
Cash Flow Statement
Daily Values
Growth Metrics
Income Statement
Consolidated Net IncomeEBITEBITDAEBTEPS (Basic)EPS (Weighted Average and Diluted)Gross ProfitIncome from Continuing OperationsIncome towards Parent CompanyInterest & Investment IncomeNet Income towards Common StockholdersNon Operating IncomeOperating ExpensesOperating IncomeOther Non Operating IncomeOther Operating ExpensesProfit After TaxResearch & DevelopmentRevenueSelling, General & AdministrativeShares Outstanding (Diluted Average)Shares Outstanding (Weighted Average)Tax ProvisionsTax Rate
Others
Ratios

Gossamer Bio (GOSS) Operating Expenses: 2022-2025

Historic Operating Expenses for Gossamer Bio (GOSS) over the last 4 years, with Sep 2025 value amounting to $62.4 million.

  • Gossamer Bio's Operating Expenses rose 43.80% to $62.4 million in Q3 2025 from the same period last year, while for Sep 2025 it was $204.9 million, marking a year-over-year increase of 15.00%. This contributed to the annual value of $174.6 million for FY2024, which is 4.97% down from last year.
  • Per Gossamer Bio's latest filing, its Operating Expenses stood at $62.4 million for Q3 2025, which was up 24.19% from $50.3 million recorded in Q2 2025.
  • In the past 5 years, Gossamer Bio's Operating Expenses registered a high of $62.4 million during Q3 2025, and its lowest value of $40.5 million during Q3 2023.
  • For the 3-year period, Gossamer Bio's Operating Expenses averaged around $47.1 million, with its median value being $46.3 million (2023).
  • In the last 5 years, Gossamer Bio's Operating Expenses decreased by 27.72% in 2023 and then spiked by 43.80% in 2025.
  • Gossamer Bio's Operating Expenses (Quarterly) stood at $54.4 million in 2022, then dropped by 9.81% to $49.0 million in 2023, then declined by 7.18% to $45.5 million in 2024, then spiked by 43.80% to $62.4 million in 2025.
  • Its last three reported values are $62.4 million in Q3 2025, $50.3 million for Q2 2025, and $46.7 million during Q1 2025.